Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Alfa Wasserman, Applied Biosystems, Bruker Daltonics, GE Healthcare, Invitrogen, MDS Sciex, Proteome Software, Serva Electrophoresis GmbH, Thermo Electron, Waters, Nonlinear Dynamics, Millipore

Premium

The following companies released new products with proteomics applications at ASMS 2005: Agilent Technologies, Alfa Wasserman, Applied Biosystems, Bruker Daltonics, GE Healthcare, Invitrogen, MDS Sciex, Proteome Software, Serva Electrophoresis GmbH, Thermo Electron, and Waters. For a list of the new products and brief descriptions, see the ASMS new products table.


Nonlinear Dynamics said last week that it will launch its Pro MST protein informatics platform at the Human Proteome Organization congress in Munich, Germany, in August. Pro MST is being developed to store, manage, and mime data generated during 2D gel and mass spectrometry experiments. Nonlinear said that data from its Progenesis and Phoretix systems will be directly imported into the system.


Millipore announced today the release of two new chemiluminescent substrates for Western blotting applications. According to the company, the Immobilon Western HRP and AP Chemiluminescent Substrates provide high signal response at mid-femtogram levels.

The two substrates save on antibody consumption by using two- to five-fold less primary and secondary antibodies than traditional, low-sensitivity substrates, Millipore said. The substrates are compatible with polyvinylidene fluoride and nitrocellulose membranes as well as commonly used buffers and blocking reagents.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more